Key statistics
As of last trade Pliant Therapeutics Inc (9PT:FRA) traded at 0.95, 9.20% above its 52-week low of 0.87, set on Feb 06, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.92 |
|---|---|
| High | 0.95 |
| Low | 0.92 |
| Bid | 0.985 |
| Offer | 1.04 |
| Previous close | 0.925 |
| Average volume | 111.11 |
|---|---|
| Shares outstanding | 61.45m |
| Free float | 59.98m |
| P/E (TTM) | -- |
| Market cap | 71.90m USD |
| EPS (TTM) | -2.87 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 14:25 GMT.
More ▼
Announcements
- Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
- Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference
- Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
- Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
- Pliant Therapeutics Provides Update on BEACON-IPF
- Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
- Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
- Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
- Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
- Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
More ▼
